|
Powered by Cell Signaling Technology |
Site Information |
---|
QVFSRsEsTQPLLDS SwissProt Entrez-Gene |
Blast this site against: NCBI SwissProt PDB |
Site Group ID: 448180 |
In vivo Characterization | |
---|---|
Methods used to characterize site in vivo: | |
Disease tissue studied: | |
Relevant cell line - cell type - tissue: |
Upstream Regulation | |
---|---|
Regulatory protein: | |
Kinases, in vitro: | |
Phosphatases, in vitro: | |
Treatments: |
Downstream Regulation | |
---|---|
Effects of modification on gp130: | |
Effects of modification on biological processes: |
References | |
---|---|
Mertins P, et al. (2016) Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55-62
27251275 Curated Info |
|
Nathanson NM (2012) Regulation of neurokine receptor signaling and trafficking. Neurochem Int 61, 874-8
22306348 Curated Info |
|
Mitsuhashi S, et al. (2005) Protein phosphatase type 2A, PP2A, is involved in degradation of gp130. Mol Cell Biochem 269, 183-7
15786731 Curated Info |
|
Gibson RM, et al. (2000) Phosphorylation of human gp130 at Ser-782 adjacent to the Di-leucine internalization motif. Effects on expression and signaling. J Biol Chem 275, 22574-82
10811661 Curated Info |